For example, in breast cancer, GR expression was linked to favorable patient outcomes in ER-positive cancer [9,10] but related to shorter breast cancer specific survival, poor prognosis, resistance to chemotherapy, and metastasis in ER-negative cancer [9,11,12]. Here, NR3C1 is linked to breast carcinoma.